MarketScreener Editorial Features Protagonist Therapeutics, Inc.
Equities
PTGX
US74366E1029
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.32 USD | +0.90% |
|
-0.36% | +29.61% |
07-07 | Protagonist Therapeutics, Inc. - Special Call | |
06-17 | Citigroup Initiates Protagonist Therapeutics at Buy With $72 Price Target | MT |
MarketScreener Editorial Features
Search
Today on Wall Street: It's just a period of market normalization | October 12, 2021 at 09:16 am | |
Analyst recommendations: Cigna, Halliburton, Nike, Nio, Trex... | October 12, 2021 at 06:20 am |
No results for this search
- Stock Market
- Equities
- PTGX Stock
- News Protagonist Therapeutics, Inc.
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition